The latest call
FetchingImpact BioMedical, INC. reported on November 9, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
$5.11+6.3%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 9, 2026
The quarter ending September 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $21K | $18K | +16.67% |
| Profit | -$645K | -$1.5M | +56.12% |
| Profit per share | -$0.08 | -$0.11 | +27.27% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Impact BioMedical, INC. reported on November 9, 2026. We are fetching the call transcript; its summary follows once the transcript is in.